Identification of an Anoikis-associated LncRNA Signature to Predict the Clinical Prognosis and Immune Function of Patients with Endometrial Cancer

  • 0Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

|

|

Summary

This summary is machine-generated.

This study identifies seven anoikis-associated long non-coding RNAs (lncRNAs) as key prognostic markers for endometrial cancer. These markers can predict patient outcomes and guide immunotherapy strategies, offering new therapeutic targets for this disease.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genomics

Background

  • Endometrial cancer is a heterogeneous malignancy with high mortality and poor prognosis in advanced stages.
  • Anoikis, a form of programmed cell death, plays a critical role in cancer development and metastasis.
  • The prognostic and therapeutic implications of anoikis-associated long non-coding RNAs (lncRNAs) in endometrial cancer are not well understood.

Purpose Of The Study

  • To develop a novel prognostic signature for endometrial cancer based on anoikis-related lncRNAs.
  • To investigate the association of these lncRNAs with tumor progression, immune function, and drug sensitivity.
  • To validate the function of a specific lncRNA, CFAP58-DT, in endometrial cancer development.

Main Methods

  • Utilized The Cancer Genome Atlas (TCGA) database for transcriptome sequencing and clinical data.
  • Employed multivariate regression and least absolute shrinkage and selection operator (LASSO) regression to construct a prognostic signature.
  • Validated the signature using receiver operating characteristic (ROC) curve and Kaplan-Meier analyses; performed gene set enrichment analysis (GSEA) and in vitro/in vivo experiments.

Main Results

  • Identified seven anoikis-associated lncRNAs (CFAP58-DT, AC004585.1, AC103563.9, AL121895.2, AC004596.1, AC010761.4, AC087564.1) with significant prognostic value.
  • The developed signature demonstrated excellent predictive accuracy (AUC = 0.757) and revealed potential roles in cellular processes and immune evasion.
  • Silencing CFAP58-DT inhibited proliferation, promoted apoptosis, and reduced tumor malignancy in experimental models.

Conclusions

  • Anoikis-associated lncRNAs are significant in endometrial cancer progression and hold potential as prognostic markers and therapeutic targets.
  • The developed prognostic signature may provide new avenues for endometrial cancer treatment and immunotherapy.
  • CFAP58-DT's validated function supports its role in endometrial cancer, warranting further mechanistic investigation.

Related Concept Videos

lncRNA - Long Non-coding RNAs 02:39

8.4K

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Non-LTR Retrotransposons 03:18

11.3K

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

MicroRNAs 01:22

3.0K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...